glp 1 drugs for perimenopause GLP-1 Agonists in Perimenopause: Unique Risks and Potential Opportunities Menopause Hormone Therapy May Boost

Efficacy and tolerability of a cream containing modified glutathione (GSH-C4), beta-Glycyrrhetic, and azelaic acids in mild-to-moderate rosacea: A pilot, assessor-blinded, VISIA and ANTERA 3-D analysis, two-center study (The Rosazel Trial)

Interestingly, several persistent clinical manifestation(s) of post-COVID symptoms in PASC patients, sustain as an aftermath from earlier SARS-CoV-2-mediated hijack of host cellular factors (i.e., ACE2, NRP1, furin, TMPRSS2, and CTSL)

Kahn SE, Hull RL, Utzschneider KM

The total response of parameters after ingestion EGCG or placebo was expressed as the total area under the curve (AUC) and calculated by the trapezoid method

The MS/MS spectra were searched against a custom database generated in Fragpipe (2025-08-20-decoys-contam-UP000000625_83333_plus_SOI_v01.fasta.fas (9040 entries)) containing the Uniprot E

This includes a vast array of studies such as investigating cellular mechanisms, exploring therapeutic potentials, drug discovery, or understanding complex biological pathways